跳至主要内容
临床试验/NCT00460538
NCT00460538已完成4 期

Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms

Milsing d.o.o.2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
48
试验地点
2
主要终点
changes in SARS (seasonal allergic rhinitis symptoms)

研究概览

简要总结

The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.

详细描述

Patients allergic to the specific pollen are divided into two groups randomly. One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal secretion. Methods used for follow up safety include side effects report, physical examination and vital signs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • history of seasonal allergic rhinitis symptoms to pollen
  • positive skin prick test to pollen
  • negative history of seasonal allergic asthma
  • male or female older than 18
  • female participants must use appropriate contraception
  • able to comply to study procedures

排除标准

  • pregnancy
  • alcohol or drug abuse
  • subject receiving antihistamines , immunotherapy or on hyposensibilisation

结局指标

主要结局

changes in SARS (seasonal allergic rhinitis symptoms)

时间窗: 6 weeks

changes in Mini RQLQ (mini rhinoconjunctivitis quality of life questionnaire)

时间窗: 6 weeks

changes in specific IgE

时间窗: 6 weeks

changes in specific IgG

时间窗: 6 weeks

次要结局

  • Prick test change(6 weeks)
  • change in eosinophilia in nasal secretion(6 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验